Analytical Control Strategy for a Stereodefined Oligonucleotide Platform: An Integrated Approach from Raw Materials to Drug Substance
Time: 10:00 am
day: Day Two AM
Details:
• Delve into Wave’s pioneered, stereodefined oligonucleotide chemistry across several
clinically viable modalities
• The comprehensive control strategy for stereoisomers that encompasses analytics of
raw materials, processes and finished drug substance
• Discussing the range of methodologies supporting the overall stereochemistry control
strategy
